China Looks At Speeding Up TCM Standardization
This article was originally published in PharmAsia News
Executive Summary
According to China's Chamber of Commerce of Medicines & Health Products Importers & Exporters, Korea will raise the standard on Chinese medicinal materials beginning April 7. The move will negatively impact China's export of traditional medicinal materials, which face quality issues. A local expert expresses concern about the possible influx of foreign higher-standard TCM preparations into the domestic market, especially from Japanese pharmaceutical companies, which are exploring their expansion into China. The government is taking initial measures to raise the quality of domestic Chinese medicinal materials and collaborate with overseas partners to establish international standards. (Click here for more - Chinese Language)
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.